Wednesday, December 21, 2022 10:29:48 AM
You're welcome Tryn2, except now it looks like I was mistaken. Apparently this is the annual renewal for the approval to make investigational medicinal products (IMP) that was granted to the factory by MHRA about this same time last year.
As others on this board have pointed out, this is good, but not quite the same as full commercial approval to produce medicinal products on a large scale for use outside of clinical trials. Advent's factory has not (yet) been granted this higher level of approval from MHRA. I think we're all hoping that full commercial manufacturing approval by MHRA will follow in a matter of days, based on some good due diligence research posted here yesterday by a fellow iHubber.
If so, then we might also expect to see a press release from the company posted shortly after the MHRA posts a notice of full commercial approval on its website.
-- OJ
As others on this board have pointed out, this is good, but not quite the same as full commercial approval to produce medicinal products on a large scale for use outside of clinical trials. Advent's factory has not (yet) been granted this higher level of approval from MHRA. I think we're all hoping that full commercial manufacturing approval by MHRA will follow in a matter of days, based on some good due diligence research posted here yesterday by a fellow iHubber.
If so, then we might also expect to see a press release from the company posted shortly after the MHRA posts a notice of full commercial approval on its website.
-- OJ
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
